PDCD1 and neoplasm: Notably, the interaction between the programmed cell death 1 (PD‐1) receptor and its ligand PD‐L1 is among the most common and extensively studied mechanisms; this interaction inhibits the immune response of CD8+ cytotoxic T cells, thereby enabling tumor cells to evade immune surveillance [7].